1. Home
  2. III vs MDWD Comparison

III vs MDWD Comparison

Compare III & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • III
  • MDWD
  • Stock Information
  • Founded
  • III 2006
  • MDWD 2000
  • Country
  • III United States
  • MDWD Israel
  • Employees
  • III N/A
  • MDWD N/A
  • Industry
  • III Professional Services
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • III Consumer Discretionary
  • MDWD Health Care
  • Exchange
  • III Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • III 249.2M
  • MDWD 208.2M
  • IPO Year
  • III 2007
  • MDWD 2014
  • Fundamental
  • Price
  • III $5.24
  • MDWD $17.84
  • Analyst Decision
  • III Buy
  • MDWD Strong Buy
  • Analyst Count
  • III 1
  • MDWD 2
  • Target Price
  • III $5.50
  • MDWD $35.00
  • AVG Volume (30 Days)
  • III 180.9K
  • MDWD 156.4K
  • Earning Date
  • III 11-06-2025
  • MDWD 08-14-2025
  • Dividend Yield
  • III 3.44%
  • MDWD N/A
  • EPS Growth
  • III N/A
  • MDWD N/A
  • EPS
  • III 0.16
  • MDWD N/A
  • Revenue
  • III $240,201,000.00
  • MDWD $19,858,000.00
  • Revenue This Year
  • III N/A
  • MDWD $20.37
  • Revenue Next Year
  • III $5.10
  • MDWD $25.91
  • P/E Ratio
  • III $33.39
  • MDWD N/A
  • Revenue Growth
  • III N/A
  • MDWD N/A
  • 52 Week Low
  • III $2.95
  • MDWD $14.14
  • 52 Week High
  • III $5.30
  • MDWD $22.51
  • Technical
  • Relative Strength Index (RSI)
  • III 63.42
  • MDWD 51.00
  • Support Level
  • III $5.10
  • MDWD $16.08
  • Resistance Level
  • III $5.29
  • MDWD $20.30
  • Average True Range (ATR)
  • III 0.13
  • MDWD 0.95
  • MACD
  • III 0.00
  • MDWD 0.26
  • Stochastic Oscillator
  • III 82.86
  • MDWD 41.71

About III Information Services Group Inc.

Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: